Posts by Sandra Ansanay-Alex
Neuria receives the Start-Up Innovation Prize of the Canton of Fribourg
Neuria gets CHF 30 000 to develop its digital therapy hidden in video games to help fight nutrition disorders On 9 November 2022, was organised the Innovation Prize Ceremony of the Canton of Fribourg. Neuria received the most votes. The winning start-up was chosen by the jury and the public through a vote organised…
Read MoreA CHF 1.6 million Innosuisse Grant for PeriVision
PeriVision was awarded an Innosuisse research grant together with the University Hospital Bern and ARTORG Center for Biomedical Engineering Research to investigate remote visual field testing in glaucoma patients. Glaucoma is one of the leading causes of blindness around the world and is a chronic condition that needs continuous monitoring. It affects c. 2%…
Read MoreMICROCITY Neuchâtel, Land of Diagnostic
A Human lean Diagnostic programme in the canton of precision watchmaking The historical heritage of high precision and core competencies in micro and nanotechnologies (micromechanics, microelectronics, advanced manufacturing) as well as its unique expertise in miniaturization, ultra-low energy consumption, reliability and complexity mean that the canton of Neuchâtel can connect all the competencies necessary…
Read MoreDomo Health and Roche develop a digital health solution to detect the first signs of respiratory infections
Domo Health, a leader in digital health, announced the launch of its clinical study in collaboration with Roche Pharma Suisse SA, that aims to develop a digital health solution detecting hypoventilation and warning signs of respiratory infections. The adoption of new digital health technologies is accelerating globally. Thanks to digital health solutions, it is…
Read MoreDebiopharm leads $6M round for YonaLink to Scale Global Growth
The swiss company invests into an Israelian SaaS Platform able to collect data and to reduce clinical trial timelines and costs Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, and YonaLink, a clinical trial software provider, announced having completed an initial funding round, raising $6 million, to scale global…
Read MoreBone marrow neurons can be rewired to enable paraplegics to walk
Jocelyne Bloch and Grégoire Courtine, two Swiss researchers, have identified a group of nerve cells unrelated to the locomotor system with the capacity to change function A new study by scientists at the .NeuroRestore research center has identified the type of neuron that is activated and remodeled by spinal cord stimulation, allowing patients to…
Read MoreInterview Sacha Sidjanski
Dr. Sacha Pierre Sidjanski is in charge of External Relations at the Faculty of Life Sciences at EPFL. He explains why the Life Sciences sector is booming in Switzerland and why the country will stay a big player in the field. ✅ A dense academic network with strong state support ✅ Researchers and…
Read More🔺4à6 BioAlps at Incyte🔺
On 22 September 2022, Jonathan Dickinson, executive vice-president at Incyte, received the Swiss Health Valley Community in Morges. About 70 people participated at the BioAlps 4à6 event at Incyte, and had the opportunity to listen to: Ela Zawislak, Head of Public Affairs, Incyte EuropeHead of Public Affairs, Incyte Europe Incyte Ekaterine Asatiani, Division…
Read MoreNovochizol SA and Alpha Chitin Partner to Produce a Chitosan-Based Polysaccharide
Alpha Chitin will manufacture both Novochizol™ raw materials and Novochizol™-based intermediate products. Alpha Chitin, a French biobased chemistry company (Lacq – Aquitaine) and producer of innovative high-quality chitosans, and Novochizol SA, a Swiss biotech (Monthey – Valais) with a unique chitosan processing technology, today announced the creation of a joint venture to realize the…
Read MoreSOPHiA GENETICS Partners with Microsoft to Accelerate Multimodal Health Data Analysis
The agreement is to expand and reinforce data-driven medicine through the SOPHiA DDM™ health data analysis platform available with Microsoft Azure SOPHiA GENETICS™ (Nasdaq: SOPH), a cloud-native software company in the healthcare sector based in Lausanne (Switzerland), is embarking on a multi-year integrated strategic partnership with Microsoft to improve healthcare workflows globally. This investment in…
Read More